| DIRECT COMPETITOR COMPARISON | |
| CBMX | AFFX | GHDX | LIFE | Industry | | Market Cap: | 46.18M | 339.66M | 549.60M | 9.08B | 99.24M | | Employees: | 59 | 1,128 | 387 | 9,700 | 65 | | Qtrly Rev Growth (yoy): | -4.10% | 4.00% | 40.50% | 121.40% | 19.70% | | Revenue (ttm): | 4.94M | 316.88M | 141.20M | 2.95B | 14.01M | | Gross Margin (ttm): | -69.53% | 51.26% | 75.88% | 64.07% | 65.67% | | EBITDA (ttm): | -13.70M | 1.48M | -5.46M | 818.22M | -12.30M | | Oper Margins (ttm): | -307.73% | -15.92% | -8.32% | 15.72% | -137.11% | | Net Income (ttm): | -18.19M | -345.42M | -11.40M | 7.87M | N/A | | EPS (ttm): | -2.671 | -5.037 | -0.400 | 0.049 | -0.32 | | P/E (ttm): | N/A | N/A | N/A | 1038.57 | 16.76 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.51 | 1.32 | | P/S (ttm): | 9.35 | 1.05 | 3.94 | 3.03 | 9.68 |
|
| AFFX = Affymetrix Inc. | | GHDX = Genomic Health Inc. | | LIFE = Life Technologies Corporation | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.08 | 0.49% | 57.77B | 12.45 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.45 | 0.15% | 13.72B | 15.88 | | Genzyme Corp. | GENZ | 51.52 | 2.26% | 13.67B | 29.37 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.98 | 0.04% | 42.28B | 18.17 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.89 | 1.41% | 9.08B | 1038.57 | | Teva Pharmaceutical Industries Limited | TEVA | 53.16 | -0.21% | 46.83B | 48.64 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.81 | 2.05% | 4.01B | 19.49 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.08 | 0.00% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.29 | -0.05% | 5.59B | 112.21 | | Pfizer Inc. | PFE | 18.59 | 1.53% | 150.01B | 15.44 | | Johnson & Johnson | JNJ | 63.30 | 0.19% | 174.65B | 13.82 | | GlaxoSmithKline plc | GSK | 42.88 | 1.42% | 108.70B | 13.53 | | Sanofi-Aventis | SNY | 39.46 | 2.15% | 103.03B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.85 | 0.99% | 126.85B | 16.72 | | RHHBY.PK | 42.29 | 2.03% | N/A | N/A | | AstraZeneca plc | AZN | 46.38 | 2.50% | 67.25B | 9.31 | | Abbott Laboratories | ABT | 54.41 | 0.31% | 84.16B | 14.74 | | Bristol-Myers Squibb Co. | BMY | 25.65 | 1.95% | 50.81B | 13.27 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | LIFE | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
Wed 6:50am -
GlobeNewswire | | • | AFFX | | Affymetrix to Webcast Presentation at the 23rd NASDAQ OMX Investor Forum
Wed 6:00am -
Business Wire | | • | GHDX | | Genomic Health to Present at Piper Jaffray Health Care Conference
Tue, Nov 24 -
PR Newswire | | • | GHDX | | 4-Star Stocks on the Upswing
Fri, Nov 20 -
at Motley Fool | | • | LIFE | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Fri, Nov 20 -
Wall Street Transcript | | • | AFFX | | CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
Thu, Nov 19 -
at Seeking Alpha | | • | LIFE | | Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
Thu, Nov 19 -
GlobeNewswire | | • | AFFX | | Trading Overview for Sequenom Inc. Issued by StockPreacher.com
Tue, Nov 17 -
GlobeNewswire | | • | LIFE | | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities
Fri, Nov 13 -
EDGAR Online | | • | GHDX | | GENOMIC HEALTH INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | AFFX | | AFFYMETRIX INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | LIFE | | Desktop Bug Detector
Thu, Nov 12 -
at Forbes.com | | • | AFFX | | Fearful Stocks for Greedy Investors
Tue, Nov 10 -
at Motley Fool | | • | GHDX | | Mad Mail: Buy the Berkshire Hathaway Split?
Mon, Nov 9 -
at CNBC | | • | GHDX | | [video] Homework
Mon, Nov 9 -
at CNBC | | • | AFFX | | AFFYMETRIX INC Files SEC form 10-Q, Quarterly Report
Fri, Nov 6 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
0.29% Nasdaq 
Competitors
